ProfileGDS4132 / 1561402_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 64% 60% 57% 54% 55% 63% 60% 75% 57% 48% 44% 46% 54% 50% 45% 42% 46% 48% 49% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101184.17564
GSM201543Muscle PCOS pioglitazone 121157.80660
GSM201544Muscle PCOS pioglitazone 161159.64757
GSM201545Muscle PCOS pioglitazone 201157.21154
GSM201829Muscle PCOS pioglitazone 231160.16655
GSM201830Muscle PCOS pioglitazon 251183.79963
GSM201831Muscle PCOS pioglitazone 271173.82660
GSM201832Muscle PCOS pioglitazone 31227.6975
GSM201833Muscle PCOS pioglitazone 41145.23357
GSM201834Muscle PCOS pioglitazone 81125.35248
GSM201835Muscle PCOS after pioglitazone 102100.46844
GSM201836Muscle PCOS after pioglitazone 122110.50446
GSM201837Muscle PCOS after pioglitazone 162128.32354
GSM201838Muscle PCOS after pioglitazone 202124.99650
GSM201839Muscle PCOS after pioglitazone 232110.90645
GSM201840Muscle PCOS after pioglitazone 252105.48842
GSM201841Muscle PCOS after pioglitazone 272104.76146
GSM201842Muscle PCOS after pioglitazone 32104.67248
GSM201843Muscle PCOS after pioglitazone 42126.62349
GSM201844Muscle PCOS after pioglitazone 8297.323340